Spots Global Cancer Trial Database for Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion
Official Title: Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion
Study ID: NCT05532475
Conditions
Study Description
Brief Summary: To assess the levels of TNF- α in vitreous samples of patients with retinal vein occlusion prior to administration of intravitreal anti-VEGF and compare them to levels in vitreous samples of normal subjects so as to investigate the association of vitreous tumor necrosis factor with the pathogenesis of retinal vein occlusion.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kasr ALainy University hospital, Cairo, , Egypt
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
